1624P Predictive factors for treatment success of second-line Nal-IRI/5-FU/FA in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) (AIO-PAK-0216).
Saved in:
| Title: | 1624P Predictive factors for treatment success of second-line Nal-IRI/5-FU/FA in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) (AIO-PAK-0216). |
|---|---|
| Authors: | Lutz, M.P.1 (AUTHOR), Ansorge, N.2 (AUTHOR), Barmashenko, G.3 (AUTHOR), Burkart, C.4 (AUTHOR), Decker, T.5 (AUTHOR), Ettrich, T.J.6 (AUTHOR), Fischer von Weikersthal, L.7 (AUTHOR), Geer, T.8 (AUTHOR), Gerhardt, A.9 (AUTHOR), Hoefling, S.10 (AUTHOR), Jacobasch, L.11 (AUTHOR), Karthaus, M.12 (AUTHOR), Koenigsmann, M.P.13 (AUTHOR), Leidig, T.14 (AUTHOR), Schulte, M.15 (AUTHOR), Schulte, N.16 (AUTHOR), Schwarzer, A.17 (AUTHOR), Siegler, G.M.18 (AUTHOR), Waldschmidt, D.T.19 (AUTHOR), Raeth, S.20 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS899-S900. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2023.09.2573 |
